These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37994559)

  • 21. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
    Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
    Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition.
    Biscussi B; Richmond V; Baier CJ; Mañez PA; Murray AP
    CNS Neurol Disord Drug Targets; 2020; 19(8):630-641. PubMed ID: 32888280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes.
    Shareghi-Boroujeni D; Iraji A; Dara M; Hashempur MH; Zare S; Hariri R; Akbarzadeh T; Saeedi M
    Future Med Chem; 2024 Aug; 16(15):1519-1535. PubMed ID: 38864182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
    Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
    Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Class of Benzo[
    Delogu GL; Begala M; Matos MJ; Crucitti D; Sogos V; Era B; Fais A
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity.
    Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
    Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
    Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives.
    Durmaz Ş; Evren AE; Sağlık BN; Yurttaş L; Tay NF
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200294. PubMed ID: 35972839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer's disease.
    Yang F; Zhao J; Chen G; Han H; Hu S; Wang N; Wang J; Chen Y; Zhou Z; Dai B; Hou Y; Liu Y
    Bioorg Chem; 2023 Apr; 133():106432. PubMed ID: 36841050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
    Hussain R; Ullah H; Rahim F; Sarfraz M; Taha M; Iqbal R; Rehman W; Khan S; Shah SAA; Hyder S; Alhomrani M; Alamri AS; Abdulaziz O; Abdelaziz MA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
    Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alptuzun V; Erciyas E; Holzgrabe U
    Bioorg Chem; 2019 Jun; 87():888-900. PubMed ID: 30538051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New indole derivatives as multitarget anti-Alzheimer's agents: synthesis, biological evaluation and molecular dynamics.
    Azmy EM; Nassar IF; Hagras M; Fawzy IM; Hegazy M; Mokhtar MM; Yehia AM; Ismail NS; Lashin WH
    Future Med Chem; 2023 Mar; 15(6):473-495. PubMed ID: 37125532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.